Clear cell carcinomas were a subtype specifically mentioned at a recent National Cancer Institute State of the Science meeting on ovarian cancer as being a priority for subtype-specific trials of novel therapeutic agents, in an attempt to identify more effective treatment [9].The molecular origins of clear cell carcinomas remain obscure.